Harnessing the potential of therapeutic agents to safeguard bone health in prostate cancer

BACKGROUND: Patients with prostate cancer are at risk of impaired bone health. Prostate cancer has a propensity to metastasize to bone, after which patients are at risk of skeletal-related events (SREs). These complications are associated with increased mortality, substantial pain, and reduced quali...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Kurt, Steger, Günther G., Niepel, Daniela, Lüftner, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283859/
https://www.ncbi.nlm.nih.gov/pubmed/29988100
http://dx.doi.org/10.1038/s41391-018-0060-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283859/
https://www.ncbi.nlm.nih.gov/pubmed/29988100
http://dx.doi.org/10.1038/s41391-018-0060-y

Ejemplares similares